Key Features
Enhance your research with our curated data sets and powerful platform features. Pluto Bio makes it simple to find and use the data you need.
Learn MoreThe molecular pathways and microenvironmental cues that choreograph the conversion of endothelial cells (ECs) into true engraftable haematopoietic stem cells (HSCs) remain undefined. This is due to lack of models to recreate the ephemeral transition from endothelial to haemogenic cells and to HSCs. Here, we have developed a novel sequential in vitro model in which by precise conditional sequential on-off expression of transcription factors: FosB, Gfi1, Runx1, and Spi1 (FGRS); and re-establishing a proper inductive vascular niche, we were able to reprogram adult mouse ECs into HSCs (rEC-HSCs) over a 28 day period. During the day 0-8 induction phase, FGRS are conditionally expressed in adult non-lymphatic ECs isolated from Runx1-IRES-GFP reporter mice and co-cultured with vascular niche. At specification phase (day 8-20), FGRS-transduced VEcad+Runx1-CD45- ECs switch on the endogenous expression of Runx1, initiating haematopoietic program and silencing EC fate in VEcad+Runx1+CD45+ cells, setting the stage for full commitment to VEcad-Runx1+CD45+ haematopoietic stem and progenitor cells (rEC-HSPCs). During expansion phase (day 20-28), the niche cells promote expansion of a large number of haematopoietic cells, at which time expression of exogenous FGRS is turned off. Subsets of rEC-HSPCs are endowed with distinctive features of rEC-HSCs, including single cell clonal multi-lineage reconstituting potential, ability to serially re-establish bone marrow HSPC compartments, reconstitute adaptive immune function in Rag1-/- mice, and long-term self-renewal capacity. Employing Runx1-IRES-GFP reporter mice enabled deconvolution of stage-specific pathways involved in generation of engraftable rEC-HSCs. Inhibition of TGF signaling along with activation of BMP and CXCL12 pathways reinforced the induction phase. Cxcr4 deficient ECs failed to undergo conversion to rEC-HSPCs, indicating that CXCL12 signaling is essential for specification and expansion phases. This reprogramming platform provides an interrogable platform to decipher pathways involved in the transition of ECs into haematopoietic cells. Our approach also facilitates devising strategies to reprogram adult ECs into abundant autologous HSCs amenable to genetic modification for treatment of genetic and acquired haematological disorders. SOURCE: Balvir Kunar, Jr. (bak2010@med.cornell.edu) - Shahin Rafii, M.D. Weill Cornell Medical College
View on GEOView in PlutoEnhance your research with our curated data sets and powerful platform features. Pluto Bio makes it simple to find and use the data you need.
Learn MoreUse Pluto's intuitive interface to analyze and visualize data for this experiment. Pluto's platform is equipped with an API & SDKs, making it easy to integrate into your internal bioinformatics processes.
Read about post-pipeline analysisView quality control data and experiment metadata for this experiment.
Request imports from GEO or TCGA directly within Pluto Bio.
Chat with our Scientific Insights team